VHT vs VXX
Vanguard Health Care ETF vs iPath Series B S&P 500 VIX Short-Term Futures ETN
VHT$305.90
Vanguard Health Care ETF
US health care sector stocks.
Expense: 0.09%Yield: 1.58%
VXX$21.66
iPath Series B S&P 500 VIX Short-Term Futures ETN
VIX short-term futures, hedge / speculation.
Expense: 0.89%Yield: 0.00%
Quick take
- • VHT has the lower expense ratio at 0.09% vs 0.89% for VXX.
- • VHT pays a higher dividend yield (1.58%).
Side-by-side metrics
| Metric | VHT | VXX |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.09% | 0.89% |
Dividend yield Trailing 12-month yield. | 1.58% | 0.00% |
AUM Assets under management — bigger funds are typically more liquid. | $20.39B | $441M |
YTD return | 7.21% | -16.85% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.57 | 45.83 |
P/E ratio | 26.41 | — |
Last price | $305.90 | $21.66 |
Inception | — | — |
Issuer | Vanguard | Barclays |
VHT top holdings
Top holdings · VHT
| LLY | Eli Lilly and Co | 13.99% |
| JNJ | Johnson & Johnson | 8.44% |
| ABBV | AbbVie Inc | 6.07% |
| UNH | UnitedHealth Group Inc | 5.44% |
| MRK | Merck & Co Inc | 4.63% |
| TMO | Thermo Fisher Scientific Inc | 2.88% |
| AMGN | Amgen Inc | 2.86% |
| GILD | Gilead Sciences Inc | 2.63% |
| ISRG | Intuitive Surgical Inc | 2.38% |
| ABT | Abbott Laboratories | 2.35% |
Sector breakdown · VHT
Technology0.0%
Financial Services0.0%
Industrials0.0%
Healthcare100.0%
VXX top holdings
Holdings data unavailable for VXX.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $20.4B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.58%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.0% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.
About VXX
VXX (iPath Series B S&P 500 VIX Short-Term Futures ETN) is VIX short-term futures, hedge / speculation. Managed by Barclays, the fund carries $441M in assets under management, an expense ratio of 0.89%.